paramethasone has been researched along with Necrobiosis Lipoidica in 1 studies
Paramethasone: A glucocorticoid with the general properties of corticosteroids. It has been used by mouth in the treatment of all conditions in which corticosteroid therapy is indicated except adrenal-deficiency states for which its lack of sodium-retaining properties makes it less suitable than HYDROCORTISONE with supplementary FLUDROCORTISONE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p737)
Necrobiosis Lipoidica: A degenerative disease of the dermal connective tissue characterized by the development of erythematous papules or nodules in the pretibial area. The papules form plaques covered with telangiectatic vessels. More than half of the affected patients have diabetes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Taniguchi, Y | 1 |
| Sakamoto, T | 1 |
| Shimizu, M | 1 |
1 other study available for paramethasone and Necrobiosis Lipoidica
| Article | Year |
|---|---|
A case of necrobiosis lipoidica treated with systemic corticosteroid.
Topics: Administration, Oral; Adult; Complement C3; Female; Humans; Immunoglobulins; Immunohistochemistry; N | 1993 |